Table 1.

Commercial brands of the bone grafts used in this study. HA: hydroxyapatite; TCP: tricalcium phosphate beta.

Bone graft material	Brand	Particle size	Dosage
Alloplastic (synthetic or inorganic material)	Alobone® Poros - Osseocon Biomateriais - Rio de Janeiro - Brazil	HA 250/1000 μm	Vials: 5.0 g
	MBCP® Biomatlante - Vigneux-de-Bretagne – France	HA: 60%; TCP: 40% 1-2 mm and 2-3 mm	Vials: 2 cc or 30 cc
	BoneCeramic® Straumann - Headquarter - Basel -Switzerland	HA: 60%; TCP: 40% 0.5-1.0 mm	Vials: 1.0 cc-0.5 g or 1.9 cc-1.0 g
	Clonos® Neoortho - Curitiba - Paraná – Brazil	HA: 75%; TCP: 25% 0.5-1.0 mm (500-1000 μm)	Syringes: 0.5 cc or 1.0 cc
	Neobone® Ceramed - Bella Vista – Santo Domingo - Rep. Dom.	HA: 75%; TCP: 25% 500-1000 μm	Vials: 0.5 g and 1.0 g
Xenogenous (nonorganic bovine bone matrix)	Cerabone® Botiss Biomaterials GMBH – Zossen, Germany	HÁ 0.5–1000 mm	Vials: 05.ml or 1.0 ml
	Bio-Oss® Geistlich Pharma - Wolhusen, CH – Switzerland	Calcium: 35-40%; phosphate: 13.5-18.5% <5% moisture/organic material 1-2 mm	Vials: 0.5 g~1.5 cc; 1 g~3 cc; or 2 g~6 cc
	GenMix® Baumer - Mogi Mirim - São Paulo – Brazil	HÁ: 65-75% 25-35% moisture/organic material 0.25-1 mm	Vials: 0.75 cc, 1.5 cc, or 3 cc
	GenOx® Baumer - Mogi Mirim - São Paulo – Brazil	HA 0.50-1.0 mm	Vials: 0.5 cc = 0.5 g or 1.0 cc = 1.0 g